指南与共识中医内科针灸推拿中医康复

推拿治疗肠易激综合征的系统评价:对未来试验的建议

A systematic review of Tuina for irritable bowel syndrome: Recommendations for future trials.
指南 / 共识 · Complement Ther Med · 2020-07-13

本系统评价评估推拿(治疗性按摩)是否比不治疗或常规医疗更有效、更安全地治疗肠易激综合征(IBS)。共纳入8项中文随机对照试验(545例参与者,5项腹泻型IBS和3项便秘型IBS),使用8种不同手法。结果显示,推拿联合常规治疗可能优于单纯常规治疗改善腹泻型IBS总体症状,但证据质量受方法学问题及推拿手法异质性限制,需大规模多中心稳健随机试验确认。

要点

  • 推拿联合常规治疗可能优于单纯常规治疗改善腹泻型IBS总体症状。
  • 推拿单用对比常规治疗在腹泻型IBS总体症状改善率上未显示显著优势。
  • 所有试验均未报告与推拿相关的不良反应,但偏倚风险普遍不明确。

核心结论

  • 推拿联合常规治疗可能优于单纯常规治疗改善腹泻型IBS总体症状,但现有方法学问题及推拿手法异质性需大规模多中心稳健随机试验确认。

研究设计与样本

  • 系统评价检索11个数据库,纳入基于Manning或Rome标准诊断的IBS随机对照试验,比较推拿(联合或不联合常规治疗)与常规治疗。
  • 共纳入8项试验(5项腹泻型IBS、3项便秘型IBS),545例参与者,使用8种不同推拿手法,所有试验均以中文发表。
  • 采用Cochrane偏倚风险评估工具评价每项试验,使用RevMan 5.3进行Meta分析。

主要发现

  • 腹泻型IBS总体症状改善率(总体症状评分改善>30%):推拿对比常规治疗未显示显著优势(RR 1.23,95%CI 0.94-1.60,197例参与者,3项研究,I2=65%)。
  • 腹泻型IBS总体症状改善率:推拿联合常规治疗对比单纯常规治疗显示更多获益(RR 1.29,95%CI 1.08-1.54,115例参与者,3项研究)。
  • 所有试验均未报告与推拿相关的不良反应。
  • 所有领域的偏倚风险普遍不明确。

关键数值与推荐

  • IBS诊断基于Manning或Rome标准。
  • 总体症状改善率定义为总体症状评分改善>30%。

临床怎么用

  • 对于腹泻型IBS患者,可考虑在常规治疗基础上联合推拿以改善总体症状。
  • 推拿单用治疗腹泻型IBS的疗效证据尚不充分,需谨慎评估。
  • 应用推拿时需关注手法异质性及方法学质量对证据可靠性的影响。

局限性

  • 所有试验均以中文发表,可能存在发表偏倚。
  • 偏倚风险普遍不明确,尤其结局评估盲法和分配隐藏方面。
  • 推拿手法异质性较大,可能影响结果合并。
  • 样本量较小,需大规模多中心试验进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This systematic review assessed whether Tuina (therapeutic massage) is more effective and safer than no treatment or routine medical treatment for irritable bowel syndrome (IBS). METHODS: Eleven databases were searched for randomized controlled trials of IBS diagnosed based on Manning or Rome criteria. Tuina with or without routine treatments (RTs) was tested against RTs. The Cochrane risk of bias was evaluated for each trial. RevMan 5.3 was used to conduct a meta-analysis. RESULTS: A total of 8 trials (5 IBS-diarrhea and 3 IBS-constipation) with 545 participants using 8 different manipulations were included. All trials were published in Chinese. For overall symptom improving rate (> 30 % improvement in overall symptom scores), it had not been shown that Tuina was significantly better than RTs (RR 1.23, 95 % CI 0.94-1.60, 197 participants, 3 studies, I2 = 65 %) for IBS-diarrhea, and Tuina combined with RTs showed more benefit than RTs alone (RR 1.29, 95 % CI 1.08-1.54, 115 participants, 3 studies) for IBS-diarrhea. All trials did not report adverse effect in relation to Tuina. Risk of bias was generally unclear across all domains. CONCLUSIONS: Tuina combined with RTs may be superior to RTs for improving overall symptom of IBS-diarrhea. Due to the existing methodological issues and the heterogeneity of Tuina manipulation, current findings need to be confirmed in large scale, multicenter, and robust randomized trials (especially on outcome assessing blinding and allocation concealment).

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Bu FL, Han M, Lu CL, et al. A systematic review of Tuina for irritable bowel syndrome: Recommendations for future trials. Complement Ther Med. 2020. PMID: 32951752. doi:10.1016/j.ctim.2020.102504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。